Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification

Rosemary Millen; W. W. B. de Kort; Mandy Koomen; Gijs J.F. van Son; Roán Gobits; Bas Penning de Vries; Harry Begthel; Maurice M.J.M. Zandvliet; Patricia Doornaert; Cornelis P.J. Raaijmakers; Maarten H. Geurts; Sjoerd G. Elias; Robert J.J. van Es; Remco de Bree; Lot A. Devriese; Stefan M. Willems; Onno Kranenburg; Else Driehuis; Hans Clevers

doi:10.1016/j.medj.2023.04.003

Back

Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification

Article 2023 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Preprint2023

Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer

Patrick W.B. Derksen, P. M. Haughton, Stefan Prekovic, Wisse E. Haakma, Else Driehuis, Hans Clevers, Stefan M. Willems

Article2024

Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer

Peter D. Haughton, Theofilos Chalkiadakis, Gerben E. Breimer, Else Driehuis, Hans Clevers, Stefan Willems, Stefan Prekovic, Patrick W.B. Derksen, Peter D. Haughton, Theofilos Chalkiadakis, Gerben E. Breimer, Else Driehuis, Hans Clevers, Stefan Willems, Stefan Prekovic, Patrick W.B. Derksen

Article2018

Head and neck squamous cell carcinoma organoids as a platform for personalized medicine

Else Driehuis, Sigrid Kolders, Lot A. Devriese, Stefan M. Willems, Hans Clevers, Remco de Bree, Emma de Ruiter

Article2019

Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapy

Else Driehuis, Sacha Spelier, Irati Beltran Hernandez, Remco de Bree, Stefan M. Willems, Hans Clevers, Sabrina Oliveira

Article2019

Abstract 1173: A novel high throughput platform for head & neck cancer organoids drug screening

Karla Queiroz, Else Driehuis, Silvia Bonilla, Henriëtte L. Lanz, Hans Clevers, Jos Joore, Paul Vulto

Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification

Discussion(0)

Related publications

Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer

Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer

Head and neck squamous cell carcinoma organoids as a platform for personalized medicine

Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapy

Abstract 1173: A novel high throughput platform for head &amp; neck cancer organoids drug screening

Abstract 1173: A novel high throughput platform for head & neck cancer organoids drug screening